Cerus Corp. (CERS)
2.285
-0.06
(-2.35%)
USD |
NASDAQ |
Oct 07, 16:00
2.285
0.00 (0.00%)
After-Hours: 16:55
Cerus Enterprise Value : 492.64M for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 492.64M |
| October 05, 2026 | 492.64M |
| October 02, 2026 | 480.55M |
| October 01, 2026 | 488.61M |
| September 30, 2026 | 500.69M |
| September 29, 2026 | 518.82M |
| September 28, 2026 | 514.80M |
| September 25, 2026 | 549.04M |
| September 24, 2026 | 547.03M |
| September 23, 2026 | 545.01M |
| September 22, 2026 | 559.12M |
| September 21, 2026 | 536.96M |
| September 18, 2026 | 555.09M |
| September 17, 2026 | 557.10M |
| September 16, 2026 | 530.91M |
| September 15, 2026 | 524.87M |
| September 14, 2026 | 534.94M |
| September 11, 2026 | 522.85M |
| September 10, 2026 | 516.81M |
| September 09, 2026 | 526.88M |
| September 08, 2026 | 532.93M |
| September 04, 2026 | 543.00M |
| September 03, 2026 | 538.97M |
| September 02, 2026 | 545.01M |
| September 01, 2026 | 547.03M |
| Date | Value |
|---|---|
| August 31, 2026 | 553.07M |
| August 28, 2026 | 555.09M |
| August 27, 2026 | 569.19M |
| August 26, 2026 | 573.22M |
| August 25, 2026 | 569.19M |
| August 24, 2026 | 563.15M |
| August 21, 2026 | 587.32M |
| August 20, 2026 | 583.29M |
| August 19, 2026 | 595.38M |
| August 18, 2026 | 577.25M |
| August 17, 2026 | 619.55M |
| August 14, 2026 | 621.57M |
| August 13, 2026 | 593.36M |
| August 12, 2026 | 567.17M |
| August 11, 2026 | 537.96M |
| August 10, 2026 | 528.90M |
| August 07, 2026 | 494.65M |
| August 06, 2026 | 488.61M |
| August 05, 2026 | 478.53M |
| August 04, 2026 | 462.42M |
| August 03, 2026 | 454.36M |
| July 31, 2026 | 454.36M |
| July 30, 2026 | 603.44M |
| July 29, 2026 | 599.41M |
| July 28, 2026 | 609.48M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DexCom, Inc. | 30.92B |
| Abbott Laboratories | 197.51B |
| AngioDynamics, Inc. | 558.41M |
| Alphatec Holdings, Inc. | 2.118B |
| AtriCure, Inc. | 2.637B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.982M |
| Revenue (Quarterly) | 57.44M |
| Total Expenses (Quarterly) | 60.38M |
| EPS Diluted (Quarterly) | -0.0147 |
| Gross Profit Margin (Quarterly) | 50.61% |
| Profit Margin (Quarterly) | -5.19% |
| Earnings Yield | -1.51% |
| Normalized Earnings Yield | -1.514 |